Search
Transcode Therapeutics Inc
RNAZAdd to Watchlist
6.210USD
+0.970+18.51%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
5.90MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+18.51%
5 Days
+27.91%
1 Month
+20.82%
6 Months
-9.08%
Year to Date
-9.08%
1 Year
-20.38%
Key Figures
5.150Open
6.300High
51.63KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
5.63%Turnover Ratio
5.240Prev. Close
4.967Low
210.31KTurnover
LossP/E Static
4.55P/B
0.00%Div Yield TTM
-47.38%ROA
20.99052wk High
3.29Volume Ratio
-16.82MNet Profit
916.97KShares
-3.7086EPS TTM
1.32Beta
-757.04%ROE
5.01052wk Low
25.44%Amplitude
--Gross Margin
5.90MMarket Cap
-0.63Reward/Risk
5.74%Risk Rate
TradingKey Stock Score
No stock score available due to insufficient data.
Transcode Therapeutics Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Transcode Therapeutics Inc Info
TransCode Therapeutics, Inc. is a clinical-stage oncology company focused on treating metastatic disease. It is defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. Its lead candidate, TTX-MC138, targets metastatic tumors overexpressing microRNA-10b, a biomarker of metastasis. The Company is also developing a portfolio of RNA therapeutic candidates to overcome delivery challenges and unlock access to novel genetic targets. Its preclinical programs include TTX-siPDL1 (siRNA modulator of PD-L1), TTX-RIGA (RNA agonist of RIG-I for innate immunity activation), and TTX-siMYC (siRNA inhibitor of c-MYC). Additionally, R&D efforts are exploring the combination of TTX-MC138 and seviprotimut-L technologies to enhance therapeutic impact.
Ticker SymbolRNAZ
CompanyTranscode Therapeutics Inc
CEOCalais (Philippe P)
Websitehttps://www.transcodetherapeutics.com/
Related Instruments
-2.50%
-1.79%
-1.22%
-0.57%
-0.73%
-0.56%
+0.44%
-0.86%
+0.01%
-2.42%
-0.58%
-1.64%
-0.76%
-1.77%
+1.01%
0.00%
-1.31%
+1.68%
+0.56%
+0.28%Popular Instruments
52112.500
-83.800 (-0.16%)
30077.100
-147.500 (-0.49%)
7460.700
-21.700 (-0.29%)
15295.000
-300.000 (-1.92%)
70431.000
-425.000 (-0.60%)
6302.000
-25.000 (-0.40%)
69.308
-0.613 (-0.88%)
289.360
+7.620 (+2.70%)
200.090
+5.120 (+2.63%)
3968.620
-38.660 (-0.96%)
FAQs
What is the current price of Transcode Therapeutics Inc (RNAZ)?
The current price of Transcode Therapeutics Inc (RNAZ) is 6.21.
What is the symbol of Transcode Therapeutics Inc?
The ticker symbol of Transcode Therapeutics Inc is RNAZ.
What is the 52-week high of Transcode Therapeutics Inc?
The 52-week high of Transcode Therapeutics Inc is 20.99.
What is the 52-week low of Transcode Therapeutics Inc?
The 52-week low of Transcode Therapeutics Inc is 5.01.
What is the market capitalization of Transcode Therapeutics Inc?
The market capitalization of Transcode Therapeutics Inc is 5.69M.
What is the Earnings Per Share (EPS TTM) of Transcode Therapeutics Inc (RNAZ)?
The Earnings Per Share (EPS TTM) of Transcode Therapeutics Inc (RNAZ) is -52.59.
